JPH0212233B2 - - Google Patents

Info

Publication number
JPH0212233B2
JPH0212233B2 JP3964481A JP3964481A JPH0212233B2 JP H0212233 B2 JPH0212233 B2 JP H0212233B2 JP 3964481 A JP3964481 A JP 3964481A JP 3964481 A JP3964481 A JP 3964481A JP H0212233 B2 JPH0212233 B2 JP H0212233B2
Authority
JP
Japan
Prior art keywords
formula
reaction
value
general formula
fluoride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3964481A
Other languages
Japanese (ja)
Other versions
JPS57156491A (en
Inventor
Hisashi Ishii
Michinori Akasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Shoyaku Co Ltd
Original Assignee
Kaken Shoyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Shoyaku Co Ltd filed Critical Kaken Shoyaku Co Ltd
Priority to JP3964481A priority Critical patent/JPS57156491A/en
Publication of JPS57156491A publication Critical patent/JPS57156491A/en
Publication of JPH0212233B2 publication Critical patent/JPH0212233B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

【発明の詳細な説明】 本発明は有用な薬理作用を有するアルカロイド
であるセフアランチン及びその類似化合物の新規
な製法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel method for producing cephalantin, an alkaloid having useful pharmacological effects, and its analogous compounds.

本発明者らは、一般式 (式中R1及びR2は低級アルキル基を示す)で表
わされる化合物を一般式 X―(CH2o−Y () (式中X及びYはハロゲン原子、nは1〜3の整
数を示す)で表わされる化合物と反応させること
により、一般式 (式中R1及びR2は低級アルキル基、nは1〜3
の整数を示す)で表わされるセフアランチン及び
その類似化合物を合成することに成功した。
The inventors have determined that the general formula (In the formula, R 1 and R 2 represent a lower alkyl group) A compound represented by the general formula ) by reacting with a compound represented by the general formula (In the formula, R 1 and R 2 are lower alkyl groups, n is 1 to 3
We succeeded in synthesizing cephalantin and its analogous compounds represented by the integer .

出発物質である式のデメチレンセフアランチ
ンは、メギ科、ツヅラフジ科、キンポウゲ科植物
等に分布するオキシアカンチン、ホモアロモリ
ン、セフアラノリンなどから製造することができ
る。
The starting material, demethylene cephalanthine of the formula, can be produced from oxyacanthine, homoaromoline, cephalanoline, etc., which are distributed in plants of the family Berberaceae, ericaceae, Ranunculaceae, etc.

式の化合物の置換基X及びYのためのハロゲ
ン原子としては、塩素原子、臭素原子が好まし
く、X及びYは同一でも異なつてもよい。
The halogen atom for the substituents X and Y in the compound of the formula is preferably a chlorine atom or a bromine atom, and X and Y may be the same or different.

本発明の反応は無機弗化物の存在下に極性非プ
ロトン溶媒中で行うことが好ましい。無機弗化物
としては弗化セシウム、弗化カリウム、弗化ルビ
ジウム、弗化リチウム、弗化ナトリウムなどが用
いられる。極性非プロトン溶媒としては、ジメチ
ルホルムアミド、ジメチルスルホキシド、ヘキサ
メチルホスホリツクトリアミドなどが用いられ
る。
The reaction of the invention is preferably carried out in a polar aprotic solvent in the presence of an inorganic fluoride. As the inorganic fluoride, cesium fluoride, potassium fluoride, rubidium fluoride, lithium fluoride, sodium fluoride, etc. are used. As the polar aprotic solvent, dimethylformamide, dimethylsulfoxide, hexamethylphosphoric triamide, etc. are used.

本反応を実施するに際しては、系内の空気をア
ルゴンガス、窒素ガス等の不活性ガスで置換して
おくことが好ましい。反応温度は100〜150℃が好
ましい。通常は30分ないし2時間で反応が終了す
る。
When carrying out this reaction, it is preferable to replace the air in the system with an inert gas such as argon gas or nitrogen gas. The reaction temperature is preferably 100 to 150°C. The reaction usually completes in 30 minutes to 2 hours.

実施例 1 淡黄色無晶性粉末のデメチレンセフアランチン
103.3mg(0.174ミリモル)を無水ジメチルホルム
アミド0.75mlに溶解する。この溶液をアルゴンガ
ス気流下に弗化セシウム184.6mg(1.22ミリモル)
に加え、室温で1時間撹拌したのち、無水臭化メ
チレン0.013ml(0.187ミリモル、d=2.4956)を
加え、110〜120℃で1時間撹拌する。反応終了
後、反応混合物にクロロホルムを加えて希釈し、
弗化セシウムを去する。液を5%水酸化ナト
リウム溶液で洗浄し、無水炭酸カリウムで乾燥し
たのち溶媒を留去すると、残留物105.6mgが得ら
れる。
Example 1 Demethylenecephalantin as pale yellow amorphous powder
103.3 mg (0.174 mmol) are dissolved in 0.75 ml of anhydrous dimethylformamide. 184.6 mg (1.22 mmol) of cesium fluoride was added to this solution under a stream of argon gas.
After stirring at room temperature for 1 hour, 0.013 ml (0.187 mmol, d=2.4956) of anhydrous methylene bromide was added, and the mixture was stirred at 110-120°C for 1 hour. After the reaction is complete, chloroform is added to the reaction mixture to dilute it.
Remove cesium fluoride. The liquid was washed with 5% sodium hydroxide solution, dried over anhydrous potassium carbonate, and the solvent was distilled off to obtain 105.6 mg of a residue.

これをシリカゲルカラム・クロマトグラフイ
(5g)を用い、クロロホルム―メタノール
(15:1)混液で溶出して精製すると、茶褐色の
油状物52.8mg(収率50.1%)が得られる。このも
のの薄層クロマトグラフイは、セフアランチン以
外に若干の不純物が存在することを示すが、
NMR値は1C6H6、1CH3COCH3の付加していな
いセフアランチンと一致した。これをベンゼン―
ジエチルエーテル混液に溶解して不溶物を除去し
たのち、ベンゼン―アセトン混液から再結晶する
と、無色プリズム晶のセフアランチン(1C6H6
1CH3COCH3付加体)25.9mg(収率20.1%)が得
られる。このもののIR値及び薄層クロマトグラ
フイのRf値は標品と一致した。
This was purified using silica gel column chromatography (5 g) and eluted with a chloroform-methanol (15:1) mixture to obtain 52.8 mg (yield 50.1%) of a brown oil. Thin layer chromatography of this product shows that there are some impurities other than cephalantin.
The NMR value was consistent with cephalanthine without addition of 1C 6 H 6 and 1CH 3 COCH 3 . This is benzene-
After dissolving in a diethyl ether mixture to remove insoluble matter, recrystallization from a benzene-acetone mixture yields colorless prismatic crystals of cephalanthine (1C 6 H 6 ,
25.9 mg (yield 20.1%) of 1CH 3 COCH 3 adduct) is obtained. The IR value and Rf value of this product by thin layer chromatography matched those of the standard product.

融点:99〜102℃ 比旋光度:〔α〕19 D+296゜(c=1.00、CHCl3) 元素分析値:C37H38N2O6・C6H6
CH3COCH3として C H N 計算値(%) 74.37 6.78 3.75 実測値(%) 74.23 6.77 3.75 実施例 2 デメチレンセフアランチン97.7mg(0.164ミリ
モル)を無水ジメチルホルムアミド0.75mlに溶解
する。この溶液をアルゴンガス気流下で弗化セシ
ウム173.5mg(1.14ミリモル)に加え、室温で1
時間撹拌したのち、臭化エチレン0.016ml(0.185
ミリモル)、d=2.172)を加え、110〜120℃で2
時間撹拌する。反応終了後、反応混合物にクロロ
ホルムを加えて希釈し、弗化セシウムを去す
る。液を5%水酸化ナトリウム溶液で洗浄し、
無水炭酸ナトリウムで乾燥したのち溶媒を留去す
ると、褐色の残留物77.4mgが得られる。
Melting point: 99-102℃ Specific rotation: [α] 19 D +296゜ (c = 1.00, CHCl 3 ) Elemental analysis value: C 37 H 38 N 2 O 6・C 6 H 6
CH 3 COCH 3 Calculated value (%) 74.37 6.78 3.75 Actual value (%) 74.23 6.77 3.75 Example 2 97.7 mg (0.164 mmol) of demethylene cephalanthine is dissolved in 0.75 ml of anhydrous dimethylformamide. This solution was added to 173.5 mg (1.14 mmol) of cesium fluoride under an argon gas flow, and
After stirring for an hour, 0.016 ml (0.185 ml) of ethylene bromide
mmol), d=2.172), and heated at 110 to 120℃ for 2 hours.
Stir for an hour. After the reaction is completed, the reaction mixture is diluted with chloroform to remove the cesium fluoride. Wash the liquid with 5% sodium hydroxide solution,
After drying over anhydrous sodium carbonate, the solvent is distilled off to obtain 77.4 mg of a brown residue.

これをアルミナカラムクロマトグラフイ
(Woelm.basic grade 8g)を用い、ベン
ゼン―酢酸エチル(10:1)混液で溶出して留去
すると、無色の粉末26.8mg(収率26.3%)が得ら
れる。これをクロロホルム―アセトン混液から再
結晶すると、融点140〜142℃の目的化合物が無色
無晶性粉末として18.0mg(収率17.6%)得られ
る。
This is distilled off using alumina column chromatography (Woelm basic grade 8g) and eluted with a benzene-ethyl acetate (10:1) mixture to obtain 26.8 mg (yield 26.3%) of a colorless powder. When this is recrystallized from a chloroform-acetone mixture, 18.0 mg (yield 17.6%) of the target compound with a melting point of 140-142°C is obtained as a colorless amorphous powder.

NMR値:δ(CDCl3) 2.10〜3.77(13H、m、脂肪族H) 2.57、2.61(each 3H、sNCH3 ×2) 3.69、3.93(each 3H、s、−OCH3 ×2) 3.77〜4.03(2H、m、−OCH2 CH2O―) 4.03〜4.33(3H、m、1位又は1′位のH及び (−OCH2CH2 O―) 5.44(1H、s、8′位のH) 6.23〜7.15(8H、m、芳香環H) 7.41(1H、d、J=8.5Hz、芳香環H) IR値:νCHCl3 naxcm-1:特徴的なピークなし MS m/e: 622(M++2、9.6%) 621(M++1、41.3%) 620(M+、基準ピーク) 619(M+−1、75.2%) 以下の式は推定構造を示す。 NMR value: δ (CDCl 3 ) 2.10-3.77 (13H, m, aliphatic H) 2.57, 2.61 (each 3H, sNC H 3 ×2) 3.69, 3.93 (each 3H, s, −OC H 3 ×2) 3.77 ~4.03 (2H, m, -OC H 2 CH 2 O-) 4.03 ~ 4.33 (3H, m, H at position 1 or 1' and (-OCH 2 CH 2 O-) 5.44 (1H, s, 8 H at position ′) 6.23-7.15 (8H, m, aromatic ring H) 7.41 (1H, d, J = 8.5Hz, aromatic ring H) IR value: ν CHCl3 nax cm -1 : No characteristic peak MS m/ e: 622 (M + +2, 9.6%) 621 (M + +1, 41.3%) 620 (M + , reference peak) 619 (M + -1, 75.2%) The following formulas show the estimated structure.

元素分析値:C38H40N2O6:1/2CHCl3・1/
2H2Oとして 計算値(%) 67.07 6.07 4.06 実測値(%) 67.12 6.02 3.91 実施例 3 デメチレンセフアランチン520mgを無水ジメチ
ルホルムアミド3.8mlに溶解する。この溶液をア
ルゴンガス気流中で弗化セシウム90mlに加え、室
温で1時間撹拌したのち1,3―二臭化プロパン
200mgを加え、120℃で16時間撹拌する。反応混合
物を氷水20mlに懸濁したのち、エーテル20mlで3
回抽出する。エーテル層を1N水酸化ナトリウム
溶液及び飽和食塩水で洗浄したのち、溶媒を減圧
留去する。残留物をシリカゲルクロマト〔ヘキサ
ン―酢酸エチル―ジエチルアミン(70:30:
0.5)〕で精製し、エーテル―酢酸エチル混液から
再結晶すると、融点142〜144℃の目的化合物が無
色無晶性粉末として5.2mg得られる。
Elemental analysis value: C 38 H 40 N 2 O 6 : 1/2 CHCl 3・1/
Calculated value (%) as 2H 2 O 67.07 6.07 4.06 Actual value (%) 67.12 6.02 3.91 Example 3 520 mg of demethylene cephalanthine is dissolved in 3.8 ml of anhydrous dimethylformamide. This solution was added to 90 ml of cesium fluoride in an argon gas stream, stirred at room temperature for 1 hour, and then added to 1,3-dibromide propane.
Add 200 mg and stir at 120°C for 16 hours. The reaction mixture was suspended in 20 ml of ice water, and then diluted with 20 ml of ether.
Extract times. After washing the ether layer with 1N sodium hydroxide solution and saturated brine, the solvent was distilled off under reduced pressure. The residue was chromatographed on silica gel [hexane-ethyl acetate-diethylamine (70:30:
0.5)] and recrystallized from an ether-ethyl acetate mixture to obtain 5.2 mg of the target compound as a colorless amorphous powder with a melting point of 142-144°C.

IR値:特徴的なピークなし MS m/e: 636(M++2) 4.1% 635(M++1) 18.3% 634(M+) 50.1% 633(M+−1) 44.0% 408 21.8% 407 79.4% 393 47.0% 204(Base) 100.0%IR value: No characteristic peak MS m/e: 636 (M + +2) 4.1% 635 (M + +1) 18.3% 634 (M + ) 50.1% 633 (M + -1) 44.0% 408 21.8% 407 79.4 % 393 47.0% 204 (Base) 100.0%

Claims (1)

【特許請求の範囲】 1 一般式 (式中R1及びR2は低級アルキル基を示す)で表
わされる化合物を一般式 X―(CH2o−Y (式中X及びYはハロゲン原子、nは1〜3の整
数を示す)で表わされる化合物と反応させること
を特徴とする、一般式 (式中R1及びR2は低級アルキル基、nは1〜3
の整数を示す)で表わされるセフアランチン又は
その類似化合物の製法。 2 無機弗化物の存在下にジメチルホルムアミド
中で反応させることを特徴とする、特許請求の範
囲第1項に記載の方法。
[Claims] 1. General formula (In the formula, R 1 and R 2 represent a lower alkyl group .) A compound represented by the general formula ) is characterized by reacting with a compound represented by the general formula (In the formula, R 1 and R 2 are lower alkyl groups, n is 1 to 3
A method for producing cephalantin or a similar compound thereof, represented by the following integer: 2. The method according to claim 1, characterized in that the reaction is carried out in dimethylformamide in the presence of an inorganic fluoride.
JP3964481A 1981-03-20 1981-03-20 Preparation of cepharanthine and analog thereof Granted JPS57156491A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3964481A JPS57156491A (en) 1981-03-20 1981-03-20 Preparation of cepharanthine and analog thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3964481A JPS57156491A (en) 1981-03-20 1981-03-20 Preparation of cepharanthine and analog thereof

Publications (2)

Publication Number Publication Date
JPS57156491A JPS57156491A (en) 1982-09-27
JPH0212233B2 true JPH0212233B2 (en) 1990-03-19

Family

ID=12558787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3964481A Granted JPS57156491A (en) 1981-03-20 1981-03-20 Preparation of cepharanthine and analog thereof

Country Status (1)

Country Link
JP (1) JPS57156491A (en)

Also Published As

Publication number Publication date
JPS57156491A (en) 1982-09-27

Similar Documents

Publication Publication Date Title
EP0744400A2 (en) Process for producing 4-trifluoromethylnicotinic acid
NL8104985A (en) OXAZOLINOSTEROIDS, METHOD FOR THE PREPARATION THEREOF, AND USE THEREOF FOR THE PREPARATION OF CORTICOSTEROIDS.
JPH0212233B2 (en)
JPS61225183A (en) Manufacture of beta-carboline
US4179452A (en) 3α,6α-Dihydroxy-5β-cholestan-24-one derivatives and process for preparing the same
JPS61186381A (en) Manufacture of ergoline derivative
JPH0227994B2 (en)
JPH0522709B2 (en)
US4029664A (en) Process for interconversion of heteroyohimbane alkaloids
JP2999889B2 (en) 1,3-Alternate-type calixarene derivatives
JPH06211798A (en) Tetrahydroisoquinoline derivative and its production
US5142091A (en) α, β-unsaturated ketones and ketoxime derivatives
KR950001277B1 (en) Process for the preparation of oxybenzene derivatives
JPS6241510B2 (en)
KR960010351B1 (en) Process for the preparation of benzoxazine derivative
JPS603071B2 (en) Method for producing 1-(α-acyloxyalkyl)-5-fluorouracils
US7057045B2 (en) Process for obtaining 17β-(substituted)-3-oxo-Δ1,2-4-azasteroids and intermediates
JP2004506628A (en) Intermediates for use in preparing vitamin E
KR850001225B1 (en) Process for preparing 3-methyl-3-(o-methoxyphenoxy)-benzo-2,4-dioxacyclohexanone
SK80094A3 (en) Method of preparation of halogenated stereoide dienes
JPS63250396A (en) 3'-azido-3'-deoxythymidine derivative
JP2782755B2 (en) Method for producing 3a, 8b-cis-dihydro-3H-5,7-dibromocyclopenta [b] benzofuran
JP2784920B2 (en) 1,3-cyclohexanedione derivative
JPH075554B2 (en) Process for producing 5-bromopyridone-3-carboxamide compound
JPH0367065B2 (en)